358,433 research outputs found

    Slow learner [picture] /

    No full text
    Part of the Stan Cross Archive of cartoons and drawings, 1912-1974.; Inscription: "Stan Cross"--In ink, lower right. "Slow Learner"--In ink, upper margin; "D"--In pencil, ipper right corner; "Page 6"--In pencil, on note attached to verso.; Also available in an electronic version via the internet at: http://nla.gov.au/nla.pic-vn4306084

    Cross-Cultural Meta-Analyses

    No full text
    In the enormous collection of cross-cultural data that have been published during the last few decades it is difficult to perceive patterns. There is a clear need for systematizing the vast amount of cross-cultural studies and for developing models that explain cross-cultural differences in psychology. Two methods of cross-cultural meta-analysis can be distinguished. First, the instrument-based method of comparing data for one instrument across countries is suitable for instruments which have been administered in many countries. Second, a domain-based meta-analysis used a thematic domain from which culture-comparative studies are sampled instead of one specific instrument or method

    Roller Spacing in the Float Glass Process

    No full text
    Case Studies in Mathematical Modelling, Bradley R, Gibson R D and Cross M (editors), Pentech Press,1981, (sole author

    A Cross-Licensing System Discourages R&D Investments In Completely Complementary Technologies

    No full text
    We consider the research and development (R&D) investment com petition of duopolistic firms in completely complementary technologies. By "completely complementary technologies," we mean that no firm can produce the goods without both of the technologies. We derive the investments competition equilibria in R&D of the two completely complementary technologies with and without a cross-licensing system. By comparing R&D investment levels in the two equilibria, we show that the cross-licensing system discourages the R&D invest ments when the duopolistic firms produce goods by using the two completely complementary technologies.completely complementary technologies, cross-licensing system, R&D investments

    Vitamin D Testing Practices in Collegiate Cross Country and Track and Field Athletes

    No full text
    Vitamin D insufficiency and deficiency has become problematic within the global population. Low levels of Vitamin D may have significant impacts on bone health and the musculoskeletal system, key factors in athletic performance. Recently, Vitamin D testing has gained popularity amongst athletic populations, but there is little research in cross country and track and field (XC and TF) collegiate athletes. The purpose of this study was to investigate the Vitamin D testing practices of NCAA sponsored XC and TF programs. Fifty-five Certified Athletic Trainers (ATs) participated in the study (43 XC and TF ATs, 12 non-XC and TF ATs). The responses of XC and TF ATs were analyzed separately and compared by region of the U.S. and NCAA Division classification. Few participants (6/30) identified their institution as having a Vitamin D testing policy in place. The six participants indicated that red flags and health history are the primary indications for Vitamin D testing while preventative screening occurs at half of the Division I institutions. There was little consensus regarding adequate Vitamin D levels and number of Vitamin D tests per year. Although, 70.6% of Division I XC and TF ATs support Vitamin D testing in their athletes while 66.7% of Divisions II and III ATs did not. In addition to testing practices, this study gathered data regarding indoor training duration and bone stress injuries for XC and TF collegiate athletes. There was no significant association between indoor training duration and region of the U.S. for XC athletes, however, there was a statistically significant association for TF athletes (p = 0.016, 0.050). Using the injury data provided, an injury incidence and frequency was calculated of which women’s XC had the highest rates (11.9, 14.1), followed by women’s TF (6.3, 9.2), men’s XC (5.4, 7.6), and men’s TF (4.1, 4.9). A major limitation of the present study was the small sample size, however, future research utilizing an increased sample size may produce different or more statistically significant results. Overall, continued education and research regarding the importance of Vitamin D and athletic performance is necessary to create universal testing policies in collegiate athletics

    Cross-Border Cooperation: Subverting Sovereignty?

    No full text
    Work on European spatial planning has led me to criticise what I call territorialism.It conceives of the world in terms of a seamless cover of sovereign stateslooking after its territory each as if it were its property. In the European Unionthough, states are enveloped by a superstructure. Does this mean that there is aEuropean territory and, if so, how does it relate to the territories of its MemberStates? The issue becomes manifest in such efforts, as there have been undertaken,to arrive at a form of European spatial planning.Spatial Planning and Strateg

    The role of vitamin D in type 1 diabetes complications: a cross sectional analysis of the Pittsburgh EDC study

    No full text
    Background: It has been postulated that vitamin D deficiency may be associated with diabetic complications. A comprehensive analysis of microvascular and macrovascular complications, however, has not been conducted in patients with type 1 diabetes. Hence, we investigated the associations between vitamin D levels and the prevalence of microalbuminuria, overt nephropathy, impaired endothelial function, end stage renal failure, confirmed distal symmetric polyneuropathy, coronary artery disease and lower extremity arterial disease in individuals with type 1 diabetes.\ud \ud Methods: We measured circulating 25(OH)D and 25(OH)D3 in 214 individuals with type 1 diabetes who participated in the 25 year clinical visit of the Pittsburgh Epidemiology of Diabetes Complications study of childhood onset type 1 diabetes (n=214, mean age = 51 years and median diabetes duration = 42 years). Cross-sectional associations of 25(OH)D and 25(OH)D3 with diabetic complications were assessed with multivariable logistic regression adjusted for diabetes duration, sex, BMI, season of visit, HbA1c, insulin dose per body weight, hypertension, HDL and non-HDL cholesterol, WBC count, estimated glomerular filtration rate and albumin to creatinine ratio, as appropriate.\ud \ud Results: Fully adjusted models revealed that each 1 ng/ml increase in 25(OH)D was associated with 3% to 6% lower odds of microalbuminuria (OR=0.97, 95% CI=0.94, 0.99), impaired eGFR (OR=0.96, 95% CI=0.93, 0.99) and confirmed distal symmetric polyneuropathy (OR=0.94, 95% CI=0.90, 0.98). Similar results were found for 25(OH)D3. These vitamin D metabolites were not independently associated with overt nephropathy, end stage renal failure, coronary heart disease or lower extremity arterial disease.\ud \ud Conclusions: In this cohort of middle-aged adults with type 1 diabetes, both higher 25(OH)D and 25(OH)D3 were related with a lower prevalence of early diabetic kidney disease and diabetic neuropathy, but not with advanced renal disease and macrovascular disease. For the interest of public health, it would be imperative to determine whether vitamin D levels can further predict the risk of developing these diabetic complications

    Cross, D M (Donald Milton), WX717

    No full text
    This record was harvested from a previous catalogue system and will be withdrawn in 2025. Information in this record may be superseded or incomplete. Visit this record in UMA's new catalogue at: https://archives.library.unimelb.edu.au/nodes/view/379774Surname: CROSS Given Name(s) or Initials: D M (DONALD MILTON) Military Service Number or Last Known Location: WX717 Missing, Wounded and Prisoner of War Enquiry Card Index Number: 7212193586 Item: [2016.0049.12067] "Cross, D M (Donald Milton), WX717

    The 8p11 myeloproliferative syndrome: a distinct clinical entity caused by constitutive activation of FGFR1

    No full text
    Several recurrent translocations that involve chromosome band 8p11 have been described in myeloid malignancies. These translocations target two distinct genes: (1) FGFR1, a receptor tyrosine kinase for fibroblast growth factors, and (2) MOZ, a putative histone acetyltransferase whose precise function remains to be defined. Disruption of FGFR1 is associated with a disease entity known as the 8p11 myeloproliferative syndrome (EMS)/stem cell leukemia-lymphoma syndrome, a chronic myeloproliferative disorder that frequently presents with eosinophilia and associated T-cell lymphoblastic lymphoma. The disease is aggressive and rapidly transforms to acute leukaemia, usually of myeloid phenotype. Currently, only allogeneic stem cell transplantation appears to be effective in eradicating or suppressing the malignant clone. To date, four gene fusions associated with distinct translocations have been described in EMS: the t(8;13)(p11;q12), t(8;9)(p11;q33), t(6;8)(q27;p11) and t(8;22)(p11q22) fuse ZNF198, CEP110, FOP and BCR, respectively, to FGFR1. The resulting fusion proteins have constitutive tyrosine kinase activity and activate multiple signal transduction pathways. These pathways and the fusion proteins are attractive targets for targeted signal transduction therap
    corecore